Conformational behavior and aggregation of ataxin-3 in SDS.
Spinocerebellar ataxia type 3 (SCA3) is one of nine polyglutamine (polyQ) diseases all characterized by the presence of intraneuronal inclusions that contain aggregated protein. Aggregation of ataxin-3, the causative protein of SCA3, has been well characterized in vitro, with both pathogenic and non...
Main Authors: | Helen M Saunders, Victoria A Hughes, Roberto Cappai, Stephen P Bottomley |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3718759?pdf=render |
Similar Items
-
Molecular tools to tackle Ataxin-3 aggregation in Machado-Joseph disease
by: Ana Cláudia Viana de Almeida
Published: (2019) -
Identification of molecular interaction surfaces in Ataxin-3: targets for anti-aggregation strategies
by: Miguel Ângelo Cardoso de Azevedo Moreira
Published: (2019) -
The relationship between aggregation and toxicity of polyglutamine-containing ataxin-3 in the intracellular environment of Escherichia coli.
by: Gaetano Invernizzi, et al.
Published: (2012-01-01) -
Polyglutamine expansion accelerates the dynamics of ataxin-1 and does not result in aggregate formation.
by: Hilde A Krol, et al.
Published: (2008-01-01) -
Ataxin-1 fusion partners alter polyQ lethality and aggregation.
by: Tina Rich, et al.
Published: (2007-01-01)